跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-QUETIAPINE FUMARATE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
APO-QUETIAPINE FUMARATE
Authorized
STANDARD
APO-QUETIAPINE FUMARATE
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f07acbd0de5ec06b
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
f07acbd0de5ec06b
Drug Approval Canada Name
APO-QUETIAPINE FUMARATE
Product Name
APO-QUETIAPINE FUMARATE
Status
Dormant
Status Date
2025-04-06
Original Market Date
2021-07-28
Din
02501678
Drug Class
Human
Dosage Form
Tablet (Immediate Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.08.04
Atc Original
N05AH04 QUETIAPINE
Atc Name
n 05 ah 04
Aig Number
0131858005
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
QUETIAPINE (QUETIAPINE FUMARATE)
300 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f07acbd0de5ec06b
Type
Standard
Back to Health Canada Approvals